In the relentless quest for answers to combat cancer, scientists are turning to innovative approaches in biomedical research, specifically through the use of xenograft and orthotopic animals. These models are shedding new light on cancer and offer promises of more effective treatments in the future.
What are xenotransplants and orthotopic transplants?
Xenotransplants involve the implantation of tissue from one species into another to study its behavior and response to treatments. When this implantation is done in the same organ of origin, it is termed orthotopic. For instance, depending on the degree of study required, it’s possible to implant a human colon tumor in the colon of the animal model or subcutaneously elsewhere. In orthotopic transplant models, an animal that has been genetically modified so its immune system is deficient or non-functional is used. This allows human cells, including cancerous ones, to grow without being attacked by the animal’s immune system in the same place of origin.
Why are they valuable in cancer research?
These models offer a crucial testing environment for studying cancer and developing effective therapies. Here are some key reasons:
Mimic the human environment Xenotransplants and orthotopic transplants allow scientists to study how human tumors behave in a biological setting closer to humans. This is essential for a better understanding of cancer biology and the development of targeted treatments.
Therapy evaluation Researchers can test a range of therapies, from chemotherapy to immunotherapy, in these models before conducting clinical trials in humans. This helps identify promising treatments and rule out those that might not be effective.
Researching treatment resistance Xenotransplants and orthotopic transplants enable the study of how tumors respond and can become resistant to treatments. This is crucial for developing strategies to combat resistance.
Personalized treatments By using cells or tissues from the patient, these models allow for the investigation of personalized treatments for specific cancers, potentially leading to more effective therapies with fewer side effects.
In recent years, significant advancements have been made using these models. For instance, it has been shown that orthotopic transplants are essential for studying patients’ immune responses to cancer and for the development of immunotherapy treatments, such as immune checkpoint inhibitors. Despite their promise, these models also face challenges, like the need to enhance similarity to the human environment and reduce costs. However, research continues to progress in overcoming these hurdles.
In conclusion, xenograft and orthotopic animals transplants are proving to be invaluable tools in cancer research. Their ability to mimic the human environment and evaluate therapies offers hope for significant advancements in the fight against this devastating disease, bringing us one step closer to more effective treatments and a deeper understanding of cancer.
Komentáře